Julie Kanter, M.D. is Professor of Medicine and Pediatrics at the University of Alabama at Birmingham School of Medicine. She leads the adult sickle cell disease program and co-leads the Lifespan Comprehensive Sickle Cell Center. She has two main research focuses: advancing novel therapies through improved understanding of biology and clinical endpoints and using dissemination and implementation science to improve access to care in sickle cell disease.
Dr. Kanter has received funding from the NIH/NHLBI, HRSA, the CDC. Dr. Kanter is also the president of the National Alliance of Sickle Cell Centers (NASCC), the first network of sickle cell centers dedicated to reducing barriers and improve access to quality care for people living with sickle cell disease.